Hospitals in Massachusetts would be allowed to share compounded medications in the event of future drug shortages under an emergency rule approved Wednesday by state health regulators.
The new regulation adopted by the Massachusetts Public Health Council stems from the deadly fungal meningitis outbreak that has been linked to a tainted steroid produced by the Framingham, Mass.-based New England Compounding Center.
The specialty pharmacy has been shut down and Westborough-based Ameridose, a sister company with the same founders as the NECC, has voluntarily recalled its produces and closed through the end of the year for inspection. Those actions have prompted concerns about potential drug shortages.
Currently, hospitals that compound drugs can only do so for use by their own patients. Under the new regulation, the medications could be shared with other hospitals if state health officials determine that a severe shortage exists. Officials stressed that no such crisis has been declared at this time.
Nationally, 490 patients have been sickened and 34 have died since the fungal meningitis outbreak started. There have been no confirmed reports of illnesses in Massachusetts.
Compounding pharmacies mix customized medications based on prescriptions.